Jon Ogg

Jon Ogg is co-founder and editor for 24/7 Wall St.

Jon has worked as a news analyst for nearly 10 years and also has experience as a broker, portfolio manager and investment adviser. He has been sourced for articles in CBS MarketWatch, E*Trade, TradeTheNews, FlyOnTheWall, Pristine, Evolution Trading, Knova Trading, Hammerstone, CNet.com, Seeking Alpha, Google Finance and other sites.

Prior to 24/7 Wall St., he formed News Contrast and was the founder of a service for active traders called TradeTheNews (which he sold in 2003) and built up a news desk that was merged into E*Trade. He also worked in Copenhagen, Denmark as a portfolio manager for European clients trading U.S. equities and ran the event-driven trading team there.

He has been a financial adviser and has advised start-up and emerging-stage companies, and started his career as a licensed broker selling fixed income to some of the largest investment managers in the United States. He received a B.B.A. in Finance from the University of Houston (1992).

Jon does not hold any positions in any stocks he writes about.

Recent Articles

More Fees Passed on to Options Traders?

The Securities and Exchange Commission (SEC) is set to vote on a proposal to cap fees for trading options.

Tech Stock Earnings: 12 Must-See Previews (INTC, AMD, GOOG, LLTC, MXIM, FCS, IBM, AAPL, VMW, EMC, YHOO, MSFT)

The two largest and most obvious tech sector earnings reports to watch this week are Intel Corporation (INTC) and Google Inc. (GOOG). There are others to watch out for as well, with Advanced Micro Devices (AMD), Linear Technology (LLTC), and Fairchild Semiconductor (FCS) all on deck this week. It is too soon for putting together color beyond basic estimates on next week's major tech earnings, but next week's biggest technology earnings are IBM (IBM), Apple Inc. (AAPL), VMware (VMW), EMC Corp. (EMC), Yahoo! (YHOO) and Micrososft (MSFT).

Casino Stocks – Option Trades on Casino Stocks

I'd say the run in casino stocks is just about over and suggest you place a bearish bet on these four casino stocks.

Celgene (CELG) Faces Make or Break Event

Celgene Corporation (CELG) is about to get a name above and beyond its Revlimid at its first R&D analyst and investor day in several years. The company plans to show its start beyond the single key identifier of Revlimid, its multiple myeloma drug, as well as Thalomid. Celgene is not a one-hit wonder with no pipeline, but the company and the drug Revlimid are almost synonymous. The company hopes to change that Thursday.

Rethinking Homebuilders Stocks (KBH, PHM, MDC, XHB)

The housing market is improving. Foreclosures are slowing. Sales are up, at least in middle income housing. BUt homebuilder stocks may be in a far different boat ahead. There is some comfort that those companies which have survived to date are likely to survive 2010 and beyond. That is why the gains have been exponential from the March 2009 lows in many stocks. But some recent analyst calls in the sector may only highlight some of the risks in remaining bullish in homebuilders despite the notion that the recovery news is now already happening.